Willmar, Minnesota, Dec 23, 2024 — Vaxxinova US proudly announces a groundbreaking development for animal health and the poultry industry. The United States Department of Agriculture (USDA) has approved importation of a live Avian metapneumovirus vaccine, Vaxxon® SHS, into the U.S. market. This unprecedented approval marks a significant milestone in the fight against Avian metapneumovirus […]
Nijmegen, NL / Brescia, IT, November 28, 2024 – Today Vaxxinova® is pleased to announce that the European Commission has granted a marketing authorization for the poultry vaccine 𝗩𝗮𝘅𝘅𝗼𝗻® 𝗡𝗗 𝗖𝗹𝗼𝗻𝗲 in the EU. The adoption follows the positive opinion from the Committee for Medicinal Products for Veterinary Use (CVMP) of the European Medicines Agency […]
Sao Paulo, November 2024 – Vaxxinova Brasil has approved its new vaccine facility in lbiuna, Sao Paulo, dedicated to the production of live vaccines against avian coccidiosis. With 4,000 m2 of constructed area and an annual production capacity of more than five times the current one, the project, which began in 2020 and was completed […]
Nijmegen, NL, October 28, 2024 – We are pleased to announce the appointment of Salim Zaidi as North West Africa Regional Manager. As of October 28, Salim Zaidi is part of the Vaxxinova team in the North West Africa region based in Alger, Algeria. Salim has an extensive experience in the Animal health Industry as […]
Nijmegen, NL, October 24 2024 – Vaxxinova will be exhibiting at EuroTier 2024 in Hanover, Germany. The bi-annual trade show is this year from Tuesday Nov 12 – Friday Nov 15, daily hours from 9 AM – 6 PM. The Vaxxinova team welcomes you to their booth in Hall 21 – F34 to discuss poultry […]
Nijmegen, NL / Brescia, IT, October 15 2024 – Today Vaxxinova is pleased to announce that the Committee for Medicinal Products for Veterinary Use (CVMP) has adopted a positive opinion, recommending the approval of Vaxxon ND Clone in the EU. Vaxxon ND Clone is a vaccine for active immunization of chickens (broilers, future layers and […]
Nijmegen, Netherlands, July 16, 2024 – we are pleased to announce that two new colleaugueas have joined Vaxxinova this month. Germany: On July 1st Dr. Benedikt Ueffing joined our business unit Aqua & International Autogenous as Sales and Marketing Director for land-based autogenous Europe. Benedikt has a veterinary degree from Veterinary University of Hanover (TiHo […]
Nijmegen, Netherlands, April 19 2024: Vaxxinova is commmitted in providing poultry producers worldwide with solutions to keep their flocks healthy. One of the tools are vaccines to prevent coccidiosis. We are proud to share the article below by Joseph Harvey as published on S&P Global in April 18, 2024. Vaxxinova is ramping up sales of […]
We are pleased to announce that Dr. Shimoji Yoshihiro has joined Vaxxinova as R&D Director for Vaxxinova Japan K.K. as of April 1, 2024. Dr. Shimoji will be responsible for all R&D activities in Vaxxinova Japan K.K located at the Choka Laboratory, Tochigi Prefecture, Japan Dr. Shimoji obtained a Ph.D. (Agricultural Sicience) at the Tokyo […]
Vietnam, March 28 2024: Agriviet and Vaxxinova host launch events in Ho Chi Minh City and Hanoi. March 28 Vaxxon Coccivet was launched in Vietnam! At the Rex Hotel in Ho Chi Minh City key opinion leaders and and key accounts from the southern part of Vietnam were introduced to Vaxxinova’s solutions for coccidiosis prevention; […]